newsfilter
← Latest News
GlobeNewswire·

Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023

CHESTERBROOK, Pa., March 27, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous